Data from an open-label extension of VISIONARY-MS support an association between gold nanocrystals and neuronal repair and remyelination in patients with stable multiple sclerosis and visual deficits, ...

As they described in Radiology Case Reports, the patient noted that she had been having increasing weakness in her left arm ...

Multiple sclerosis (MS) is a chronic disease of the central nervous system that is thought to be an autoimmune disorder where ...

Tolebrutinib was found to delay disability progression in people with nonrelapsing secondary progressive MS in a Phase 3 ...

Background Previous natural history studies highlighted a consistent heterogeneity of disability trajectories among ...

What is Parkinsonism? Parkinsonism is a neurological disorder that affects the movement of the body. It is named after James ...

New research led by a St. Michael's Hospital clinician-scientist and published in the New England Journal of Medicine ...

The New England Journal of Medicine (NEJM) published positive results from the HERCULES phase 3 study demonstrating that tolebrutinib delayed disability progression in people with non-relapsing ...

The researchers suggest clinicians might tailor their approach to account for Asian Americans' younger average age when they ...

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis Results from the HERCULES phase 3 study showed delay in disability progression in people ...

American neurologist Stephen Hauser and Italian epidemiologist Alberto Ascherio were awarded the prestigious Breakthrough Prize on Sunday for their groundbreaking research on multiple sclerosis ...

An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis on Saturday won a prestigious Breakthrough Prize, the award nicknamed the ...